Clinical efficacy of infliximab plus methotrexate in DMARD naive and DMARD refractory rheumatoid arthritis is associated with decreased synovial expression of TNF alpha and IL18 but not CXCL12.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples